Reynolds MW - Search Results

1

Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility.

Rivera DR, Gokhale MN, Reynolds MW, Andrews EB, Chun D, Haynes K, Jonsson-Funk ML, Lynch KE, Lund JL, Strongman H, Bhullar H, Raman SR. Rivera DR, et al. Among authors: reynolds mw. Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):18-29. doi: 10.1002/pds.4918. Pharmacoepidemiol Drug Saf. 2020. PMID: 31950565

2

Guidelines for good database selection and use in pharmacoepidemiology research.

Hall GC, Sauer B, Bourke A, Brown JS, Reynolds MW, LoCasale R. Hall GC, et al. Among authors: reynolds mw. Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):1-10. doi: 10.1002/pds.2229. Epub 2011 Nov 8. Pharmacoepidemiol Drug Saf. 2012. PMID: 22069180 Free article.

3

Considerations when evaluating real-world data quality in the context of fitness for purpose.

Reynolds MW, Bourke A, Dreyer NA. Reynolds MW, et al. Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1316-1318. doi: 10.1002/pds.5010. Epub 2020 May 6. Pharmacoepidemiol Drug Saf. 2020. PMID: 32374042 Free PMC article. No abstract available.

4

Considerations for defining medication exposure when analyzing real-world data.

Clary A, Lin ND, Lasky T, Reynolds MW, Chokkalingam A, Rodriguez-Watson C. Clary A, et al. Among authors: reynolds mw. Pharmacoepidemiol Drug Saf. 2023 Aug;32(8):933-937. doi: 10.1002/pds.5613. Epub 2023 Apr 20. Pharmacoepidemiol Drug Saf. 2023. PMID: 36929112 No abstract available.

5

Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry.

Largent J, Xie Y, Knuth KB, Toovey S, Reynolds MW, Brinkley E, Mack CD, Dreyer NA. Largent J, et al. Among authors: reynolds mw. BMJ Open. 2023 Jun 19;13(6):e069118. doi: 10.1136/bmjopen-2022-069118. BMJ Open. 2023. PMID: 37336535 Free PMC article.

6

COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness.

Reynolds MW, Xie Y, Knuth KB, Mack CD, Brinkley E, Toovey S, Dreyer NA. Reynolds MW, et al. Infect Drug Resist. 2022 Sep 3;15:5167-5182. doi: 10.2147/IDR.S373183. eCollection 2022. Infect Drug Resist. 2022. PMID: 36090603 Free PMC article.

7

Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study.

Chow TW, Raupp M, Reynolds MW, Li S, Kaeser GE, Chun J. Chow TW, et al. Among authors: reynolds mw. Pharmaceuticals (Basel). 2024 Mar 22;17(4):408. doi: 10.3390/ph17040408. Pharmaceuticals (Basel). 2024. PMID: 38675371 Free PMC article.

8

COVID-19 Vaccination Reactions and Risk of Breakthrough Infections Among People With Diabetes: Cohort Study Derived From Community Reporters.

Dreyer NA, Knuth KB, Xie Y, Reynolds MW, Mack CD. Dreyer NA, et al. Among authors: reynolds mw. JMIR Diabetes. 2024 Feb 27;9:e45536. doi: 10.2196/45536. JMIR Diabetes. 2024. PMID: 38412008 Free PMC article.

9

Clinical reference dosimetry for the 0.5 T inline rotating biplanar Linac-MR.

Yip E, Tari SY, Reynolds MW, Sinn D, Murray BR, Fallone BG, Oliver PA. Yip E, et al. Among authors: reynolds mw. Med Phys. 2024 Apr;51(4):2933-2940. doi: 10.1002/mp.16951. Epub 2024 Feb 3. Med Phys. 2024. PMID: 38308821

10

Daily COVID-19 symptom assessment over 28 days - findings from a daily direct-to-patient registry of COVID-19 positive patients.

Brinkley E, Knuth K, Kwon T, Mack C, Leister-Tebbe H, Bao W, Reynolds MW, Dreyer N. Brinkley E, et al. Among authors: reynolds mw. J Patient Rep Outcomes. 2023 Dec 7;7(1):128. doi: 10.1186/s41687-023-00668-7. J Patient Rep Outcomes. 2023. PMID: 38060047 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters